Roselie E Achten

7PUBLICATIONS
15CO-AUTHORS
Oral and maxillofacial surgeryGene and molecular therapyMolecular targetsDental therapeutics, pharmacology and toxicologyOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 29, 2026
Long-Term Ocular Outcomes of Dupilumab in Atopic Dermatitis: Results From the BioDay Registry.

|Sep 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten

|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.

Roselie Achten, Judith Thijs, Marlot van der Wal

|Mar 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis.

Roselie Achten, Judith Thijs, Marlot van der Wal

|Jan 27, 2023
High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease.

Roselie Achten, Judith Thijs, Marlot van der Wal

Pageof 2

Frequent Collaborators

6 joint publications

Marjolein S de Bruin-Weller

5 joint publications

Daphne S Bakker

4 joint publications

Judith Thijs

3 joint publications

Edward Knol